Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, January 28, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - MONDAY, FEBRUARY 1ST, 2010
Previous Mid Day Report Next Mid Day Report >>>

DOW 0 0 (NaN) | NASDAQ 0 0 (NaN) | S&P 500 0 0 (NaN)
Report Released : 2/1/2010 1:02:28 PM
Price is: Above 52W High and Less Than 52W High but within 0% of the 52 Week High
Volume Is: At least 0% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page


NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.


Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
CFI - NYSE - MANUFACTURING - Textile Manufacturing
Culp Inc
$13.18 +0.17
1.31%
NA $13.25 -0.53% 90,219
134.66%
67,000
Most Recent Note for CFI - 2/1/2010 12:30:35 PM
Erratic sales and earnings history, below guidelines of the investment system. Hit a new 52-week high today, extended from any sound base.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
EL - NYSE - CONSUMER NON-DURABLES - Personal Products
Estee Lauder Cos Cl A
$53.41 +0.89
1.69%
NA $53.98 -1.06% 1,499,265
78.25%
1,916,100
Most Recent Note for EL - 2/1/2010 12:40:42 PM
Annual earnings history is below guidelines. Consolidating in a tight trading range above its prior base.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HSP - NYSE - DRUGS - Drug Delivery
Hospira Inc
$50.35 -0.29
-0.57%
NA $52.45 -4.00% 600,896
79.43%
756,500
Most Recent Note for HSP - 2/1/2010 12:41:47 PM
This high-ranked Medical - Generic Drugs industry firm is consolidating above its 50 DMA line. That short-term average line provided support since it turned up from its low of $21.21 and rallied sharply in March of 2009. Recent quarters showed sales revenues turning up after a slight downturn, while earnings per share increases have been above the +25% guideline in the 2 most recent comparisons versus the year ago period. It has steady earnings history, but not a very strong annual earnings (A criteria) record.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ISSI - NASDAQ - ELECTRONICS - Semiconductor - Memory Chips
Integrated Silicon Solut
$6.22 +0.45
7.80%
NA $6.29 -1.11% 364,013
222.64%
163,500
Most Recent Note for ISSI - 2/1/2010 12:49:26 PM
Hit a new 52-week high today, ralling from support at its 50 DMA line last week. Annual earnings history is below guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PRGO - NYSE - DRUGS - Drug Related Products
Perrigo Co Plc
$44.02 -0.26
-0.59%
NA $44.83 -1.81% 633,298
81.14%
780,500
Most Recent Note for PRGO - 2/1/2010 1:00:12 PM
Perched near all-time highs after recently clearing its 2008 high. Quarterly sales revenues and earnings increases on a quarterly and annual basis have not been strong and steady enough to meet strict guidelines of the investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SPR - NYSE - FINANCIAL SERVICES - Closed-End Fund - Debt
Spirit Aerosystems Hldgs
$21.25 -0.20
-0.93%
NA $22.10 -3.85% 602,897
111.94%
538,600
Most Recent Note for SPR - 2/1/2010 1:01:37 PM
Sales and earnings growth below guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us